🔍 Intelligence Synthesis JP/EN
Ethics · Regulation · Technology — Pharma Practice Notes
Article digest · Oct 20 PM

AI, Welfare & Long-term Care — what each story says

Every story in this issue with a short summary, so you can decide what to read before leaving the site. Summaries are written by AI (Claude) only from each publisher's own description and checked by Jev for anything not in that description. They are not full translations. Follow "Read the original" for the full story.

5 stories4 with summaries4 topics

🤝 AI on the care floor1

digitimes10/20 08:48 UTC

Wistron Medical Technology and Chang Gung University expand AI elder-care training

Wistron Medical Technology and Chang Gung University of Science and Technology signed a memorandum of understanding at the university.

Read the original →

🏛️ Policy and insurance1

Medical Sapo Net10/20 00:58 UTCJapanese

Expert View: Medical DX, Generative AI and the Role of Clinics in 2040, by Atsuo Tsuchiya

Toward 2040, a shortage of healthcare workers is a bigger challenge than rising patient numbers, and clinics are expected to serve as hubs linking outpatient, home and nursing care. Tsuchiya outlines a direction of maintaining and expanding regional medical functions through productivity gains from medical DX and generative AI, online consultations, information sharing and AI agents.

Read the original →

🇯🇵 Japan care and AI1

PR TIMES10/08 07:00 UTCJapanese

Cloud-based care software "Care-Ju Free" registered as eligible IT tool for 2026 digitalization and AI adoption subsidy

Good Tree Inc. issued a press release on October 8, 2026 at 11:09. It announced that its cloud-based care software has been registered as an eligible IT tool under the "Digitalization and AI Adoption Subsidy 2026."

Read the original →

🇯🇵 Welfare and AI in Japan2

Chosunbiz10/19 05:30 UTCJapanese

Health ministry proposes government data center to support medical AI and new drug development

The Ministry of Health and Welfare raised the need for a government-level data center to prepare for growing data demand in medical AI and new drug development. Expanding AI use in medicine and biotech requires a stable supply of large-scale computing infrastructure for learning from and analyzing data.

Read the original →
The analysis and visual summary are in the Oct 20 PM issue. Japanese version here.